🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Let’s play a little game. Let’s say that you’re the CSO at a cancer pharma company, and you have to choose a target to go after. Here’s a gene – high expression is associated with poor prognosis in brain cancer. Looks like a good candidate for an inhibitor right?

Huge congratulations to Digbijay Mahat for his transformative technology to map polymerases in single cells, scGRO-seq, today in nature. Endless applications!! It was such an honor to have the opportunity to contribute to this work. nature.com/articles/s4158…

scGRO-seq | Single-cell nascent RNA sequencing unveils coordinated global transcription | Nature nature.com/articles/s4158… from Phillip Sharp Lab

x.com/DigbijayMahat/…

Thanks to Anne Trafton Massachusetts Institute of Technology (MIT) News for the piece!